newsfilter
← Latest News
PR Newswire·

PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia

VANCOUVER, BC, July 24, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE:PREV) (OTCQB:PRVCF) (FSE: 18H), is pleased to announce that PreveCeutical is furthering the